HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Avani C Modi Selected Research

Ambulatory Care (Outpatient Care)

1/2021Supporting treatment adherence regimens in children with epilepsy: A randomized clinical trial.
1/2020Keeping people with epilepsy safe during the COVID-19 pandemic.
1/2019Quality of life improves with integrated behavioral health services in pediatric new-onset epilepsy.
1/2018Antiepileptic drug behavioral side effects and baseline hyperactivity in children and adolescents with new onset epilepsy.
1/2018Adherence to antiepileptic drugs in adolescents with epilepsy.
10/2012White coat adherence over the first year of therapy in pediatric epilepsy.
5/2011Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy.
8/2009Perceived barriers to clinic appointments for adolescents with sickle cell disease.
4/2008One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Avani C Modi Research Topics

Disease

29Epilepsy (Aura)
01/2022 - 04/2008
6Seizures (Absence Seizure)
10/2019 - 05/2011
5Obesity
03/2013 - 04/2006
5Cystic Fibrosis (Mucoviscidosis)
02/2011 - 03/2010
3Sickle Cell Anemia (Hemoglobin S Disease)
11/2019 - 08/2009
3Weight Loss (Weight Reduction)
09/2013 - 12/2008
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2013 - 04/2008
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022
1Contracture
01/2020
1Malnutrition (Nutritional Deficiencies)
01/2020
1COVID-19
01/2020
1Muscular Dystrophies (Muscular Dystrophy)
01/2020
1Respiratory Insufficiency (Respiratory Failure)
12/2019
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
12/2019
1Pain (Aches)
01/2018
1Morbid Obesity
03/2015
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
12/2012
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
04/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2010
1Infections
06/2009

Drug/Important Bio-Agent (IBA)

18Anticonvulsants (Antiepileptic Drugs)IBA
01/2022 - 04/2008
2N 30IBA
02/2014 - 01/2009
2Anti-Bacterial Agents (Antibiotics)IBA
02/2011 - 03/2010
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2022
1(3,4,5- trimethoxy- N- (2- methoxyethyl)- N- (4- phenyl- 2- thiazolyl)benzamideIBA
01/2022
1IronIBA
01/2020
1Hydroxyurea (Hydrea)FDA LinkGeneric
11/2019
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2017
1Biological ProductsIBA
11/2014
1Pharmaceutical PreparationsIBA
12/2012
1SolutionsIBA
06/2009
1Tobramycin (Nebcin)FDA LinkGeneric
06/2009
1Insulin (Novolin)FDA Link
04/2008
1CarbohydratesIBA
04/2008

Therapy/Procedure

16Therapeutics
01/2021 - 04/2008
9Ambulatory Care (Outpatient Care)
01/2021 - 04/2008
7Bariatric Surgery
01/2020 - 04/2006
2Self Medication
01/2018 - 05/2010
1Noninvasive Ventilation
12/2019
1Glycemic Control
07/2013
1Activities of Daily Living (ADL)
12/2012
1Kidney Transplantation
04/2010
1Gastric Bypass (Roux-en-Y Gastric Bypass)
05/2009